Diabetes and Obesity in Renal Disease in 2019, an update
The fast growing prevalence of obesity, metabolic syndrome and type 2 diabetes is an important challenge in nephrology. These entities are deeply interrelated. In fact, obesity and metabolic syndrome frequently precede diabetes. Also, overweight, obesity, hypertension, dyslipidemia, pre-diabetes and diabetes are risk factors for renal disease. Obesity itself can cause specific renal disease such as obesity-related glomerulopathy or increase the risk for progression of kidney diseases irrespective of the underlying cause. The pathways involved in renal disease associated with obesity, metabolic syndrome and diabetes are not completely known. Renal lipotoxicity and inflammation are major areas of research and could be involved in renal damage in these metabolic complications. Evidence of complementary small and large animal models may help to understand renal disease in these conditions. Finally, recent evidence in cardiovascular and renal protection of specific diets and new medications seem to offer promising alternatives to patients with type 2 diabetes and renal disease. All these topics will be discussed in the new meeting of DIABESITY, a working group of the ERA-EDTA.
November 15 and 16, 2019
Campus de Alcorcón de la Universidad Rey Juan Carlos
08:30 Introduction to DIABESITY: Welcome (Gema Medina – Spain)
09:00 “Which obese is at risk for renal disease” (Manuel Praga – Spain)
Obesity and renal disease: Clinical aspects
09:45 “Obesity: a factor for progression in established CKD” (Gema Fernández – Spain)
10:15 “Bariatric Surgery in patients with CKD” (Maruja Navaro – Spain)
10:45 Coffee break
11:30 “NASH and renal disease: cross talks between the liver and the kidney” (Manuel Romero-Gómez – Spain)
14:30 “The role of Nox derived ROS in diabetic complications” (Karin Jandeleit-Dahm – Australia)
15:00 “New aspects of Renal Lipotoxicity” (Gema Medina – Spain)
15:30 “Molecular control of tissue resident macrophage identity by nuclear receptors” (Mercedes Ricote – Spain)
16:00 Lunch break
16:30 Short communications
18:00 Abstracts session
Saturday, November 16, 2019
Life style interventions and renal disease
09:00 “Mediterranean diet to prevent cardiovascular and renal diseases” (Josep Tur – Spain)
Lessons from animal models
09:45 “Small and large animal models of obesity and renal disease” (Antonio González-Bulnes – Spain)
10:15 “Regression of diabetic kidney disease in animal models” (Josep Maria Cruzado – Spain)
10:45 Coffee break
Lessons form clinical trials in diabetes
11:35 “20 years of clinical trials: looking behind, looking ahead” (Mattias Trillini – Italy)
12:30 Lunch break
New treatment principles
14:00 “SGLT-2 inhibitors and GLP-1 agonists, an overview and emerging data” (Mads Hornum – Denmark)
14:30 “New molecules in the treatment of Cardiovascular-renal diseases” (Cristina Rondinone – United Kingdom)
15:00 Coffee break
Novel biomarkers and monitoring of diabetic disease
15:30 “Markers of renal disease in obesity and diabetes” (Alberto Ortiz – Spain)
16:00 “Glycated Albumin and Continous Glucose Monitoring in CKD and dialysis patients” (Tobias Bomholt – Denmark)
16:30 “Future directions in Diabesity and renal disease” (Enrique Morales – Spain)
Diabesity Working Group welcomes the submission of abstracts for original works in the field of diabetes, obesity and renal diseases. The Scientific Committee of the CME will make the selection of abstracts for Poster Presentation or Oral Communication.
Please send your abstract as a PDF document to the following e-mail address: firstname.lastname@example.org
with the subject:
The abstract submission deadline will be October, 15, 2019.
You will receive an e-mail message confirming our receipt of your abstract.
The Presenting Author of each abstract accepted will be notified before October 24,
2019. If the Presenting Author is unable to present the abstract, another co-author can take his/her place.
Submitted abstracts must describe unpublished work. Abstracts body must include 700 words, a table and a figure. Please also include complete affiliation of all the authors.
Only abstracts with at least one author registered to attend the course will be included in course materials and displayed at Diabesity Madrid-Alcorcón 2019 CME Course.
All authors of correctly written and successfully submitted abstracts will receive confirmation by e-mail.
Subway station, Line 8, Airport T1, T2, T3 / Airport T4 to Subway station, Line 8, Nuevos Ministerios. Change to subway line 10 to Cuatro Vientos. Change to Cercanías Train Cuatro Vientos to Alcorcón, Line C-5, direction Móstoles el Soto. From there, walk 15 minutes to Campus de Alcorcón URJC.